Get the Stockscreener App
3.12
7.86%
-0.25
After Hours:
3.12
Annexon Inc stock is traded at $3.12, with a volume of 5.02M.
It is down -7.86% in the last 24 hours and up +50.73% over the past month.
Annexon Inc is a clinical-stage biopharmaceutical company developing a pipeline of novel therapies for patients with classical complement-mediated disorders of the body, brain, and eye. Its pipeline is based on its platform technology addressing well-researched classical complement-mediated autoimmune and neurodegenerative disease processes, both of which are triggered by aberrant activation of C1q. Its pipeline of product candidates is designed to block the activity of C1q and the entire classical complement pathway in a broad set of complement-mediated diseases. Its product candidates are ANX005, for autoimmune & neurodegenerative disorders; ANX007, for neurodegenerative ophthalmic disorders; ANX1502 for Oral small molecule; and ANX009, for systemic autoimmune diseases.
See More
Previous Close:
$3.37
Open:
$3.38
24h Volume:
5.02M
Relative Volume:
2.92
Market Cap:
$342.85M
Revenue:
-
Net Income/Loss:
$-134.24M
P/E Ratio:
-1.7627
EPS:
-1.77
Net Cash Flow:
$-121.34M
1W Performance:
+4.19%
1M Performance:
+50.73%
6M Performance:
+38.00%
1Y Performance:
-49.43%
1-Day Range:
$3.02
$3.425
1-Week Range:
$2.75
$3.425
52-Week Range:
$1.285
$7.85
Annexon Inc Stock (ANNX) Company Profile
Name
Annexon Inc
Sector
Industry
Phone
(650)-822-5500
Address
1400 SIERRA POINT PARKWAY, BRISBANE
Compare ANNX with other stocks
| Stocks | Price | Market Cap | Revenue | Net Income | Cash Flow | EPS |
|---|---|---|---|---|---|---|
ANNX
Annexon Inc
|
3.12 | 370.32M | 0 | -134.24M | -121.34M | -1.77 |
|
VRTX
Vertex Pharmaceuticals Inc
|
395.31 | 98.90B | 11.39B | 3.64B | 3.50B | 13.99 |
|
ALNY
Alnylam Pharmaceuticals Inc
|
447.49 | 58.51B | 2.46B | -319.09M | -52.09M | -2.47 |
|
REGN
Regeneron Pharmaceuticals Inc
|
560.70 | 59.77B | 14.21B | 4.46B | 3.56B | 39.68 |
|
ARGX
Argen X Se Adr
|
719.04 | 43.55B | 3.06B | 1.28B | 447.35M | 21.30 |
|
ONC
Beone Medicines Ltd Adr
|
332.83 | 35.81B | 3.81B | -644.79M | -669.77M | -6.24 |
Annexon Inc Stock (ANNX) Upgrades & Downgrades
| Date | Action | Analyst | Rating Change |
|---|---|---|---|
| Mar-01-24 | Upgrade | JP Morgan | Neutral → Overweight |
| Dec-21-23 | Upgrade | BofA Securities | Neutral → Buy |
| Oct-30-23 | Initiated | Wells Fargo | Overweight |
| May-26-23 | Downgrade | BofA Securities | Buy → Neutral |
| May-25-23 | Downgrade | JP Morgan | Overweight → Neutral |
| Sep-16-22 | Initiated | Jefferies | Buy |
| Sep-09-22 | Initiated | BTIG Research | Buy |
| Nov-30-21 | Initiated | H.C. Wainwright | Buy |
| Sep-23-21 | Initiated | Cantor Fitzgerald | Overweight |
| Jan-26-21 | Initiated | Needham | Buy |
| Aug-18-20 | Initiated | BofA Securities | Buy |
| Aug-18-20 | Initiated | Cowen | Outperform |
| Aug-18-20 | Initiated | JP Morgan | Overweight |
View All
Annexon Inc Stock (ANNX) Latest News
Multi asset correlation models including Annexon Inc.July 2025 Weekly Recap & Technical Analysis for Trade Confirmation - newser.com
Will Annexon Inc. stock maintain momentum in 2025July 2025 Weekly Recap & Fast Exit and Entry Strategy Plans - newser.com
Building trade automation scripts for Annexon Inc.Day Trade & Fast Momentum Entry Tips - newser.com
Is Annexon Inc. stock bottoming out2025 Support & Resistance & Daily Profit Maximizing Trade Tips - newser.com
Why Annexon Inc. stock is seen as undervaluedGlobal Markets & Free High Return Stock Watch Alerts - newser.com
Price action breakdown for Annexon Inc.2025 Short Interest & Stepwise Trade Signal Guides - newser.com
Will Annexon Inc. stock outperform Nasdaq indexEarnings Recap Summary & Weekly High Return Stock Opportunities - newser.com
Statistical indicators supporting Annexon Inc.’s strengthQuarterly Investment Review & Stepwise Entry/Exit Trade Alerts - newser.com
Does Annexon Inc. show high probability of reboundWeekly Trend Recap & Community Verified Swing Trade Signals - newser.com
Is Annexon Inc. stock entering bullish territory2025 Price Action Summary & Weekly Stock Performance Updates - newser.com
What data driven models say about Annexon Inc.’s futureEarnings Miss & Safe Swing Trade Setups - newser.com
Is now a turning point for Annexon Inc.2025 Breakouts & Breakdowns & Low Drawdown Momentum Ideas - newser.com
Gainers Report: Is Annexon Inc. affected by consumer sentimentQuarterly Market Summary & Daily Market Momentum Tracking - خودرو بانک
Annexon Inc. stock trendline breakdownJuly 2025 Trends & Stepwise Trade Signal Guides - newser.com
Using flow based indicators on Annexon Inc.July 2025 Retail & Real-Time Chart Pattern Alerts - newser.com
Pattern recognition hints at Annexon Inc. upside2025 Technical Overview & Weekly High Return Forecasts - newser.com
Measuring Annexon Inc.’s beta against major indicesCEO Change & Fast Momentum Stock Entry Tips - newser.com
Published on: 2025-09-19 13:33:12 - newser.com
Combining machine learning predictions for Annexon Inc.GDP Growth & Safe Capital Growth Plans - newser.com
Trend Recap: Does Annexon Inc offer margin of safety2025 Macro Impact & Fast Exit Strategy with Risk Control - خودرو بانک
Market Review: Is now the right time to enter Black Spade Acquisition II Co Equity WarrantJuly 2025 Update & Entry and Exit Point Strategies - خودرو بانک
Portfolio Update: Will Annexon Inc stock benefit from M AWeekly Market Outlook & High Accuracy Investment Entry Signals - خودرو بانک
Update Report: Is Annexon Inc. in a bullish channel2025 Technical Overview & Accurate Intraday Trading Signals - خودرو بانک
Market Catalysts: Can Annexon Inc. grow without dilutionJuly 2025 Outlook & Weekly Watchlist for Consistent Profits - خودرو بانک
Fund Flows: Is Annexon Inc. being accumulated by smart money2025 Analyst Calls & Fast Entry Momentum Trade Alerts - خودرو بانک
What to do if you’re stuck in Annexon Inc.Weekly Trade Analysis & Accurate Buy Signal Alerts - newser.com
Annexon Inc Stock (ANNX) Financials Data
Revenue
Net Income
Cash Flow
EPS
0.98%
0.09%
Open in Yahoo
|
Open in Google
|
Open in Finviz
|
Open in MarketWatch
|
Open in EDGAR
|
Open in Reuters
Cap:
|
Volume (24h):